Ergothioneine rescues PC12 cells from β-amyloid-induced apoptotic death

被引:98
作者
Jang, JH
Aruoma, OI
Jen, LS
Chung, HY
Surh, YJ [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Lab Biochem & Mol Toxicol, Seoul 151742, South Korea
[2] Univ London Imperial Coll Sci Technol & Med, Dept Neuroinflammat, Div Neurosci & Psychol Med, Fac Med, London W6 8RF, England
[3] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea
基金
新加坡国家研究基金会;
关键词
Alzheimer's disease; apoptosis; beta-amyloid; ergothioneine; oxidative and/or nitrosative stress; peroxynitrite; free radicals;
D O I
10.1016/j.freeradbiomed.2003.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid (Abeta) peptide is the major component of senile plaques and considered to have a causal role in the development and progression of Alzheimer's disease. There has been compelling evidence that Abeta-induced cytotoxicity is mediated through oxidative and/or nitrosative stress. Recently, considerable attention has been focused on dietary manipulation of oxidative and/or nitrosative damage. L-Ergothioneine (EGT; 2-mereaptohistidine trimethylbetaine) is a low-molecular-weight naturally occurring thiol compound of dietary origin that exists in the brain, liver, kidney, erythrocytes, ocular tissues, and seminal fluids of mammals. This water-soluble antioxidant has the ability to scavenge hydroxyl and peroxynitrite radicals as well as activated oxygen species, such as singlet oxygen. In this study, we investigated the effects of EGT on Abeta-induced oxidative and/or nitrosative cell death. Rat pheochromocytorna (PC12) cells treated with Abeta underwent apoptotic death as determined by positive in situ terminal end-labeling (TUNEL staining), decreased mitochondrial transmembrane potential, increased ratio of proapoptotic Bax to antiapoptotic BCl-X-L, elevated caspase-3 activity, and cleavage of poly(ADP-ribose) polymerase. EGT pretreatment attenuated Abeta-induced apoptosis in PC12 cells. Compared to N-acetyl-L-cysteine, which mainly scavenges reactive oxygen species, EGT effectively inhibited Abeta-induced cell death by suppressing peroxynitrite formation and subsequent nitration of protein tyrosine residues. The effects of EGT on the cytotoxicity induced by the nitric oxide donor sodium nitroprusside (SNP) and the peroxynitrite-generating 3-morpholinosydnonimine chlorhydrate (SIN-1) were compared. Whereas EGT significantly protected against SIN-1-mediated cell death, it barely affected the cytotoxicity induced by SNP. Thus EGT may attenuate apoptosis caused by Abeta, preferentially by eliminating peroxynitrite derived from the neurotoxic peptide. The importance of diet-derived antioxidants in the management of Alzheimer's disease and other neurodegenerative disorders is discussed. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:288 / 299
页数:12
相关论文
共 42 条
[1]   THE ANTIOXIDANT ACTION OF ERGOTHIONEINE [J].
AKANMU, D ;
CECCHINI, R ;
ARUOMA, OI ;
HALLIWELL, B .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 288 (01) :10-16
[2]   Protection against oxidative damage and cell death by the natural antioxidant ergothioneine [J].
Aruoma, OI ;
Spencer, JPE ;
Mahmood, N .
FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (11) :1043-1053
[3]   Antioxidant action of ergothioneine: Assessment of its ability to scavenge peroxynitrite [J].
Aruoma, OI ;
Whiteman, M ;
England, TG ;
Halliwell, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (02) :389-391
[4]   One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: Redox reaction involving ergothioneine and vitamin C [J].
Asmus, KD ;
Bensasson, RV ;
Bernier, JL ;
Houssin, R ;
Land, EJ .
BIOCHEMICAL JOURNAL, 1996, 315 :625-629
[5]   Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches [J].
Behl, C .
PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) :301-323
[6]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554
[7]   Nitric oxide synthases:: targets for therapeutic strategies in neurological diseases [J].
Chabrier, PE ;
Demerlé-Pallardy, C ;
Auguet, M .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) :1029-1035
[8]  
DYRKS T, 1992, J BIOL CHEM, V267, P18210
[9]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[10]  
Good PF, 1996, AM J PATHOL, V149, P21